The use of a melagatran and inogatran and their derivatives for the manufacture of a medicament for the treatment of idiopathic pulmonary fibrosis (IPF) and pulmonary fibrosis

摘要

Use of a gatran, such as inogatran or melagatran, or a pharmaceutically-acceptable derivative thereof, for the manufacture of a medicament for the treatment of pulmonary fibrosis is disclosed.